Mixed Topics
Feature
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate Markers
As the FDA’s use of surrogate endpoints in the drug approval process is increasing, researchers are concerned important postapproval or validation...
Latest News
Study Evaluates CVD, Mortality Risks In Patients With Prurigo Nodularis
Studies have shown increased risks for cardiovascular diseases in patients with prurigo nodularis, but limited sample sizes have hindered further...
Conference Coverage
Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity
“We now have a definitive result in a robustly conducted trial that will take the field forward,” says an author of the new research.
Latest News
Consider Skin Cancer, Infection Risks in Solid Organ Transplant Recipients
There are over 450,000 people with a solid organ transplant living in the United States.
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
Feature
Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained
A snapshot assessment of metabolic syndrome is inadequate to show an association with cancer risk over time, the authors of new research say.
Feature
Does worsening metabolic syndrome increase the risk of developing cancer?
Elevated trajectories of metabolic syndrome were associated with an elevated overall cancer risk.
Latest News
Study Finds No Increased Cancer Risk With Spironolactone
Spironolactone, used off-label for several skin conditions in women, carries a warning about an increased tumor risk associated with high doses in...
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.
Latest News
Is Metformin a ‘Drug for All Diseases’?
Long time diabetes medication, metformin may have utility in treatment of obesity, liver disease, cancers, and other diseases.
Latest News
The Ghost Research Haunting Nordic Medical Trials
Numerous studies could be considered ‘medical research waste’ or research that was never shared publicly, study finds.